MUSC Health names CEO of Charleston division, system chief clinical officer

Charleston-based Medical University of South Carolina Health has tapped David Zaas, MD, to serve as CEO of MUSC Health’s Charleston division and chief clinical officer of MUSC Health.

Advertisement

Dr. Zaas is scheduled to begin his roles in July. He will lead the MUSC Hospital Authority in Charleston, oversee executive leaders of the Charleston division and serve on the MUSC Health System Council, MUSC Health said. He will also help guide health system strategies. 

Dr. Zaas most recently was president of Duke Raleigh (N.C.) Hospital. He also held leadership positions at Durham, N.C.-based Duke University, including CMO of Duke Faculty Practice Diagnostic Clinic and medical director of Duke University Hospital.

Dr. Zaas received his medical degree from from Northwestern University Medical School in Chicago, and he has an MBA from Duke University. 

 

More articles on executive moves:
5 recent hospital, health system executive retirements
Mohawk Valley Health System names chief physician executive
Texas health system CEO steps down

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

  • Hospital and health system CEOs across the U.S. have made several moves recently, including appointments at new organizations and departures.…

  • Ned Resch has resigned as president and CEO of Scottsbluff, Neb.-based Regional West Health Services. Mr. Resch had led the…

  • Tacoma, Wash.-based MultiCare Health System has named Ellen Wiegand senior vice president and chief information officer. Ms. Wiegand joins the…

Advertisement

Comments are closed.